John Klement
Hematology & Oncology
Credentials: · · ·
History
Research
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion
Journal of Clinical Investigation · 2018 · First of 10 authors · 311 citations
Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation
Review · Cancers · 2020 · 127 citations
Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
The Journal of Immunology · 2021 · 119 citations
11 papers
6 papers
3 papers
3 papers
2 papers
- AF
1 paper · 1 as a fellow
1 paper
1 paper
